Skip to content

Bill Schiffner

FDA approves the Cyltezo Pen

FDA approves the Cyltezo Pen

RIDGEFIELD, Conn. – Boehringer Ingelheim announced Monday that the U.S. Food and Drug Administration (FDA) has approved the Cyltezo Pen, a new autoinjector option for Cyltezo (adalimumab-adbm), an FDA-approved Interchangeable biosimilar to Humira (adalimumab).

Circana launches Passport+

Circana launches Passport+

 CHICAGO – Circana, formerly IRI and The NPD Group, today announced the launch of Passport+, unleashing outsize growth for small to midsize CPG companies through comprehensive data, insight, and reporting solutions.

Walmart reports strong Q1 results

Walmart reports strong Q1 results

BENTONVILLE, Ark. – Walmart said Thursday that revenue increased 7.6% to $152.3 billion in its first quarter, topping Wall Street expectations. The company also raised its fiscal 2024 forecast; management now expects consolidated net sales will rise about 3.5% this year.

Target reports first-quarter earnings

Target reports first-quarter earnings

Target Corp. said sales increased 0.5% in its first quarter, with strength in everyday essentials offsetting continued softness in sales of discretionary items. Beauty was Target’s quarter’s best-performing category in the quarter to April 29, with sales growing in the mid-teens from a year earlier.